FDA permits marketing of first medical device for treatment of ADHD
The FDA permitted marketing of the first medical device to treat ADHD. The prescription-only device, called the Monarch external Trigeminal Nerve Stimulation System, is indicated for patients ages 7 to12 years old who are not currently taking prescription ADHD medication. April 19, 2019